Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Colinz Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Colinz Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Colinz Laboratories Q4 net profit up 13.33% at Rs 0.17 cr

    29 Apr 2026, 6:10PM The company reported standalone net profit of Rs 0.17 crore for the quarter ended March 31, 2026 as compared to Rs 0.15 crore in the same period last
  • Colinz Laboratories - Financial Results For The Quarter And Year Ended On 31-03-2026

    29 Apr 2026, 5:39PM As required under Regulations 33 of SEBI(LODR), Regulation ,2015 , we are attaching herewith the Financial Results for the Quarter and Year Ended on 3
  • Colinz Laboratories - Board Meeting Outcome for Disclosure Under Regulation 30 And Other Applicable Provisions Of The Securit

    29 Apr 2026, 5:32PM In terms of provisions of Regulation 30 (read with Part A of Schedule III) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
  • Colinz Laboratories - Integrated Filing (Financial) For The Quarter And Year Ended 31St March 2026

    29 Apr 2026, 4:20PM Pursuant to SEBI Circular SEBI/HO/CFD/-POD-2024/185 dated 31-12-2024 read with BSE Circular No. 20250102-4 we are submitting herewith the Integrate
  • Colinz Laboratories - Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR

    21 Apr 2026, 3:25PM Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 ,inter alia, to consider
  • Colinz Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    15 Apr 2026, 2:20PM As of March 2026, 66.00% is owned by Indian Promoters and 34.00% by Public. <p align=justify> Top five Promoters holding highest number of shares of C
  • Colinz Laboratories - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviatio

    3 Apr 2026, 12:35PM Dear Sir,\r\n\r\nPlease find the attached Statement of Non -Applicability of Regulation 24A for Deviation or Variation from the Proceeds of Public Is
  • Colinz Laboratories - Non - Applicability Of Annual Secretarial Compliance Report Under Regulation 24A Of SEBI (LODR) Regulat

    3 Apr 2026, 12:29PM Dear Sir,\r\n\r\nPlease find the attached Non-Applicability Certificate as required under Regulation 24A of SEBI (LODR), Regulation,2015 for the Year
  • Colinz Laboratories - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(

    3 Apr 2026, 12:23PM Dear Sir,\r\n\r\nPlease find the attached Non -Applicability of Related Party Trasaction Certificate for the Quarter Ended on Mar-26 as required und
  • Colinz Laboratories - Confirmation Of Not Being Identified As Large Corporate In Terms Of SEBI Circular No. SEB

    3 Apr 2026, 12:19PM Please find the attached Non -applicability of Not being identified as a Large Corporate as per the para 2.2 of the Circular Issued Dated 26-11-201.

Key fundamentals

Evaluate the intrinsic value of Colinz Laboratories Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 10.433 10.1153 9.5187 8.4126 8.1719
Liabilities 10.433 10.1153 9.5187 8.4126 8.1719
Equity 2.5191 2.5191 2.5191 2.5191 3.545
Gross Profit 0.4076 0.4951 0.5428 0.6089 0.5861
Net Profit 0.5145 0.4966 0.4867 0.4574 0.3393
Cash From Operating Activities 2.5411 -1.4537 1.0347 0.4029 0.4671
NPM(%) 8.38 7.6 6.92 6.39 4.86
Revenue 6.1361 6.5277 7.0296 7.1549 6.9742
Expenses 5.7285 6.0326 6.4868 6.546 6.3881
ROE(%) 5.16 4.98 4.88 4.59 3.4

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Colinz Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 799.55 1.28 47.27 28.25 301.39 0.63
Lotus Eye Hospital and Institute Ltd 115.05 -2.95 375.45 102.94 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 19.47 12.15 0.00 213.74 -39.50 0.00
Astec Lifesciences Ltd 707.00 -1.21 0.00 97.08 -363.15 0.00

Company Info

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Read More

Parent Organisation

Colinz Laboratories Ltd.

Founded

06/10/1986

Managing Director

NSE Symbol

FAQ

The current price of Colinz Laboratories Ltd is

The 52-week high for Colinz Laboratories Ltd is

The market capitalization of Colinz Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Colinz Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Colinz Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Colinz Laboratories Ltd shares.

The CEO of Colinz Laboratories Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT